HDAC inhibitors show promise against cancer stem cells

medicalxpress.com October 3, 2016

A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate stubborn reservoirs of breast and ovarian cancer stem cells (CSCs).

cancer inhibitors stem cells study treatment

Fluid Personalization and Vasopressor Decisions in Early Sepsis Management

Fluid Personalization and Vasopressor Decisions in Early Sepsis Management

AKI Risk Factors in ICU Patients Using Colistin

AKI Risk Factors in ICU Patients Using Colistin

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Omadacycline Treatment of Severe Pneumonia Complicated with ARDS During COVID-19

Omadacycline Treatment of Severe Pneumonia Complicated with ARDS During COVID-19

The Ventilator Book

Identification of Biomarkers, New Treatments, and Vaccines for COVID-19

Case Files Emergency Medicine, Fourth Edition

Pulmonary Hypertension: Controversial and Emerging Topics

Complications: A Surgeon’s Notes on an Imperfect Science

Ketamine for Treatment-Resistant Depression

Manual of ICU Procedures

Sepsis Management: PIRO and MODS

Extracorporeal Life Support for Adults

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Critical Care: A New Nurse Faces Death, Life, and Everything in Between